Enhanced Pulmonary Vasodilator Reserve and Abnormal Right Ventricular: Pulmonary Artery Coupling in Heart Failure with Preserved Ejection Fraction

Circulation: Heart Failure

Volumn 8, Issue 3, 2015, Pages 542-550

  Andersen, Mads J ^a,b   Hwang, Seok Jae ^a,c   Kane, Garvan C ^a   Melenovsky, Vojtech ^a,d   Olson, Thomas P ^a   Fetterly, Kenneth ^a   Borlaug, Barry A ^a  

^a MAYO CLINIC ROCHESTER   (United States)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c Gyeongsang National University   (South Korea)

^d INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

heart failure; heart failure, diastolic; hypertension, pulmonary; pulmonary circulation; ventricular function, right

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; BETA 1 ADRENERGIC RECEPTOR STIMULATING AGENT;

ADULT; ARTICLE; BETA ADRENERGIC STIMULATION; CLINICAL ARTICLE; COMPLIANCE (PHYSICAL); CONTROLLED STUDY; DIASTOLE; DIASTOLIC DYSFUNCTION; DRUG INFUSION; ECHOCARDIOGRAPHY; FEMALE; GAS ANALYSIS; HEART AFTERLOAD; HEART CATHETER; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART MUSCLE CONTRACTILITY; HEMODYNAMIC MONITORING; HEMODYNAMIC PARAMETERS; HUMAN; INVASIVE PROCEDURE; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; LUNG VASOCONSTRICTION; MALE; MIDDLE AGED; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; PULMONARY VASCULAR DISEASE; REST; VASODILATATION; AGED; ARTERIAL PRESSURE; CARDIOVASCULAR SYSTEM EXAMINATION; COMPLICATION; CONTROLLED CLINICAL TRIAL; DRUG EFFECTS; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE FUNCTION; HEART STROKE VOLUME; HYPERTENSION, PULMONARY; INFUSION; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROSPECTIVE STUDY; VERY ELDERLY;

ADRENERGIC BETA-1 RECEPTOR AGONISTS; AGED; AGED, 80 AND OVER; ARTERIAL PRESSURE; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; DOBUTAMINE; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION, PULMONARY; INFUSIONS, PARENTERAL; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PULMONARY ARTERY; STROKE VOLUME; VASODILATION; VENTRICULAR DYSFUNCTION, RIGHT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT;

EID: 84938545364     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.114.002114     Document Type: Article

References (37)

1. Borlaug BA, Paulus WJ. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J. 2011;32:670-679. doi: 10.1093/eurheartj/ehq426.
2. Lam CS, Roger VL, Rodeheffer RJ, Borlaug BA, Enders FT, Redfield MM. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol. 2009;53:1119-1126. doi: 10.1016/j.jacc.2008.11.051.
3. Damy T, Kallvikbacka-Bennett A, Goode K, Khaleva O, Lewinter C, Hobkirk J, Nikitin NP, Dubois-Randé JL, Hittinger L, Clark AL, Cleland JG. Prevalence of, associations with, and prognostic value of tricuspid annular plane systolic excursion (TAPSE) among out-patients referred for the evaluation of heart failure. J Card Fail. 2012;18:216-225. doi: 10.1016/j.cardfail.2011.12.003.
4. Guazzi M, Bandera F, Pelissero G, Castelvecchio S, Menicanti L, Ghio S, Temporelli PL, Arena R. Tricuspid annular plane systolic excursion and pulmonary arterial systolic pressure relationship in heart failure: an index of right ventricular contractile function and prognosis. Am J Physiol Heart Circ Physiol. 2013;305:H1373-H1381. doi: 10.1152/ajpheart.00157.2013.
5. Melenovsky V, Hwang SJ, Lin G, Redfield MM, Borlaug BA. Right heart dysfunction in heart failure with preserved ejection fraction. Eur Heart J. 2014;35:3452-3462. doi: 10.1093/eurheartj/ehu193.
6. Burke MA, Katz DH, Beussink L, Selvaraj S, Gupta DK, Fox J, Chakrabarti S, Sauer AJ, Rich JD, Freed BH, Shah SJ. Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction. Circ Heart Fail. 2014;7:288-299. doi: 10.1161/CIRCHEARTFAILURE.113.000854.
7. Guazzi M, Borlaug BA. Pulmonary hypertension due to left heart disease. Circulation. 2012;126:975-990. doi: 10.1161/CIRCULATIONAHA. 111.085761.
8. Rowell LB. Human Cardiovascular Control. Oxford University Press; 1993.
9. Chattopadhyay S, Alamgir MF, Nikitin NP, Rigby AS, Clark AL, Cleland JG. Lack of diastolic reserve in patients with heart failure and normal ejection fraction. Circ Heart Fail. 2010;3:35-43. doi: 10.1161/CIRCHEARTFAILURE.108.824888.
10. Lee AP, Song JK, Yip GW, Zhang Q, Zhu TG, Li C, Chan A, Yu CM. Importance of dynamic dyssynchrony in the occurrence of hypertensive heart failure with normal ejection fraction. Eur Heart J. 2010;31:2642-2649. doi: 10.1093/eurheartj/ehq248.
11. Norman HS, Oujiri J, Larue SJ, Chapman CB, Margulies KB, Sweitzer NK. Decreased cardiac functional reserve in heart failure with preserved systolic function. J Card Fail. 2011;17:301-308. doi: 10.1016/j. cardfail.2010.11.004.
12. Charoenpanichkit C, Little WC, Mandapaka S, Dall'Armellina E, Morgan TM, Hamilton CA, Hundley WG. Impaired left ventricular stroke volume reserve during clinical dobutamine stress predicts future episodes of pulmonary edema. J Am Coll Cardiol. 2011;57:839-848. doi: 10.1016/j.jacc.2010.10.019.
13. Ohara T, Niebel CL, Stewart KC, Charonko JJ, Pu M, Vlachos PP, Little WC. Loss of adrenergic augmentation of diastolic intra-LV pressure difference in patients with diastolic dysfunction: evaluation by color M-mode echocardiography. JACC Cardiovasc Imaging. 2012;5:861-870. doi: 10.1016/j.jcmg.2012.05.013.
14. Downing SE, Lee JC. Nervous control of the pulmonary circulation. Annu Rev Physiol. 1980;42:199-210. doi: 10.1146/annurev. ph.42.030180.001215.
15. Porcelli RJ, Viau A, Demeny M, Naftchi NE, Bergofsky EH. Relation between hypoxic pulmonary vasoconstriction, its humoral mediators and alpha-beta adrenergic receptors. Chest. 1977;71(2 suppl):249-251.
16. Salvi SS. Alpha1-adrenergic hypothesis for pulmonary hypertension. Chest. 1999;115:1708-1719.
17. Abenhaim L, Moride Y, Brenot F, Rich S, Benichou J, Kurz X, Higenbottam T, Oakley C, Wouters E, Aubier M, Simonneau G, Bégaud B. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. N Engl J Med. 1996;335:609-616. doi: 10.1056/NEJM199608293350901.
18. Borlaug BA, Nishimura RA, Sorajja P, Lam CS, Redfield MM. Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail. 2010;3:588-595. doi: 10.1161/CIRCHEARTFAILURE.109.930701.
19. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-1463. doi: 10.1016/j.echo.2005.10.005.
20. Abudiab MM, Redfield MM, Melenovsky V, Olson TP, Kass DA, Johnson BD, Borlaug BA. Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction. Eur J Heart Fail. 2013;15:776-785. doi: 10.1093/eurjhf/hft026.
21. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23:685-713; quiz 786. doi: 10.1016/j.echo.2010.05.010.
22. Haddad F, Hunt SA, Rosenthal DN, Murphy DJ. Right ventricular function in cardiovascular disease, part I: anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation. 2008;117:1436-1448. doi: 10.1161/CIRCULATIONAHA.107.653576.
23. Borlaug BA, Kass DA. Invasive hemodynamic assessment in heart failure. Cardiol Clin. 2011;29:269-280. doi: 10.1016/j.ccl.2011.03.003.
24. Raff GL, Glantz SA. Volume loading slows left ventricular isovolumic relaxation rate. Evidence of load-dependent relaxation in the intact dog heart. Circ Res. 1981;48(6 Pt 1):813-824.
25. Leeuwenburgh BP, Steendijk P, Helbing WA, Baan J. Indexes of diastolic RV function: load dependence and changes after chronic RV pressure overload in lambs. Am J Physiol Heart Circ Physiol. 2002;282:H1350-H1358. doi: 10.1152/ajpheart.00782.2001.
26. Dupont M, Mullens W, Skouri HN, Abrahams Z, Wu Y, Taylor DO, Starling RC, Tang WH. Prognostic role of pulmonary arterial capacitance in advanced heart failure. Circ Heart Fail. 2012;5:778-785. doi: 10.1161/CIRCHEARTFAILURE.112.968511.
27. Aronson D, Eitan A, Dragu R, Burger AJ. Relationship between reactive pulmonary hypertension and mortality in patients with acute decompensated heart failure. Circ Heart Fail. 2011;4:644-650. doi: 10.1161/CIRCHEARTFAILURE.110.960864.
28. Miller WL, Grill DE, Borlaug BA. Clinical features, hemodynamics, and outcomes of pulmonary hypertension due to chronic heart failure with reduced ejection fraction: pulmonary hypertension and heart failure. JACC Heart Fail. 2013;1:290-299. doi: 10.1016/j.jchf.2013.05.001.
29. Guazzi M, Vicenzi M, Arena R, Guazzi MD. Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study. Circulation. 2011;124:164-174. doi: 10.1161/CIRCULATIONAHA.110.983866.
30. Redfield MM, Chen HH, Borlaug BA, Semigran MJ, Lee KL, Lewis G, LeWinter MM, Rouleau JL, Bull DA, Mann DL, Deswal A, Stevenson LW, Givertz MM, Ofili EO, O'Connor CM, Felker GM, Goldsmith SR, Bart BA, McNulty SE, Ibarra JC, Lin G, Oh JK, Patel MR, Kim RJ, Tracy RP, Velazquez EJ, Anstrom KJ, Hernandez AF, Mascette AM, Braunwald E; RELAX Trial. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA. 2013;309:1268-1277. doi: 10.1001/jama.2013.2024.
31. Zile MR, Bourge RC, Redfield MM, Zhou D, Baicu CF, Little WC. Randomized, double-blind, placebo-controlled study of sitaxsentan to improve impaired exercise tolerance in patients with heart failure and a preserved ejection fraction. JACC Heart Fail. 2014;2:123-130. doi: 10.1016/j.jchf.2013.12.002.
32. Bonderman D, Pretsch I, Steringer-Mascherbauer R, Jansa P, Rosenkranz S, Tufaro C, Bojic A, Lam CS, Frey R, Ochan Kilama M, Unger S, Roessig L, Lang IM. Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, singledose study. Chest. 2014;146:1274-1285. doi: 10.1378/chest.14-0106.
33. Lewis GD, Bossone E, Naeije R, Grünig E, Saggar R, Lancellotti P, Ghio S, Varga J, Rajagopalan S, Oudiz R, Rubenfire M. Pulmonary vascular hemodynamic response to exercise in cardiopulmonary diseases. Circulation. 2013;128:1470-1479. doi: 10.1161/CIRCULATIONAHA.112.000667.
34. Bergofsky EH. Mechanisms underlying vasomotor regulation of regional pulmonary blood flow in normal and disease states. Am J Med. 1974;57:378-394.
35. Krum H, Sobotka P, Mahfoud F, Böhm M, Esler M, Schlaich M. Devicebased antihypertensive therapy: therapeutic modulation of the autonomic nervous system. Circulation. 2011;123:209-215. doi: 10.1161/CIRCULATIONAHA.110.971580.
36. Borlaug BA, Olson TP, Lam CS, Flood KS, Lerman A, Johnson BD, Redfield MM. Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. J Am Coll Cardiol. 2010;56:845-854. doi: 10.1016/j.jacc.2010.03.077.
37. Borlaug BA, Melenovsky V, Russell SD, Kessler K, Pacak K, Becker LC, Kass DA. Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation. 2006;114:2138-2147. doi: 10.1161/CIRCULATIONAHA.106.632745.